Received Jul 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
patient was administered only the adjuvant; patient was administered only the adjuvant; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 99-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On 08-JUL-2025, the patient received Arexvy. On 08-JUL-2025, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient was administered only the adjuvant) and inappropriate dose of vaccine administered (Verbatim: patient was administered only the adjuvant). On 08-JUL-2025, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 08-JUL-2025 The Health Care Professional (Pharmacist) called to report that a patient was administered only the adjuvant of Arexvy vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered